Associate Director, Global Health Economics and Outcomes Research

Associate Director, Global Health Economics and Outcomes Research page is loaded## Associate Director, Global Health Economics and Outcomes Research locations:
MA – Massachusetts – Remote time type:
Full time posted on:
Posted Todayjob requisition :
JR 000424

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH.

Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration.

To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way.
** About Madrigal Pharmaceuticals:
** Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH.

Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration.

To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way.
*
* Job Description:

** The Associate Director, Global Health Economics & Outcomes Research (GHEOR), Real-World Evidence (RWE) will support the strategic goals of the GHEOR, Global Medical Affairs (GMA) and the broader business driving patient access with optimal pricing and reimbursement for Madrigal Pharmaceutical’s medicines, with a focus on Rezdiffra.

This position directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our medicines for liver health, with a primary focus on developing and deploying real-world data and evidence to support Rezdiffra and the Madrigal portfolio, in a federated operating model that includes service delivery across the enterprise.

This role will be responsible for developing and executing RWE projects and strategies against the global integrated evidence plans, including dissemination of technical deliverables related to real-word data and evidence. Reporting to the Director, GHEOR (RWE), the incumbent will be working closely with the GMA, Clinical Development & Biostatistics, Access and Commercial, Regional and in-Country teams to foster a culture that promotes innovation, optimal population health and patient centricity.

This role will report to the Director, GHEOR (RWE).All incumbents are responsible for adhering to applicable Madrigal policies and procedures.
** Key Responsibilities and Primary

Activities:

** Approximately 60% of this role focuses on executing functional objectives, and 40% is dedicated to providing…